This site is intended for healthcare professionals only
LoginRegister
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaSun Pharma's lowball bid for Taro opposed by Krensavage Asset Management
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeUSFDA concludes inspection at Dr Reddy's Labs Srikakulam facility with zero observations
Submit Revised protocol for Torsemide ER tablets: CDSCO Tells SyngeneSubmit Revised protocol for Torsemide ER tablets: CDSCO Tells Syngene
Medicamen Biotech files ANDA for Bortezomib for injection with USFDAMedicamen Biotech files ANDA for Bortezomib for injection with USFDA
GSK, Pfizer resolve patent lawsuit over RSV vaccinesBaby powder suit: Johnson and Johnson must pay USD 18.8 million to California cancer patient
USFDA nod to JnJ Tremfya for Crohns diseaseJnJ sues in latest bid to halt Medicare drug price negotiations
Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitisEli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference
Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger PartnerPfizer, Flagship Pioneering partner to create new pipeline of innovative medicines
Novartis opens new radioligand therapy manufacturing facility in CaliforniaSubmit Revise Protocol for TIN-816 : CDSCO panel Tells Novartis
Piramal Pharma gets SEBI go ahead to raise up to Rs 1050 crore through rights issuePiramal Pharma gets SEBI go ahead to raise up to Rs 1050 crore through rights issue
Compugen wins on PVRIG European patent opposition pursued by GSK, a third partyCompugen wins on PVRIG European patent opposition pursued by GSK, a third party
Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitisPhase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen
X